Your College Grad Moving Home: Save Now, Secure Retirement
A wave of Class of 2026 graduates is moving back home as costs rise. This story explains how families can support sav...
Investing
Learn smart investing strategies for stocks, ETFs, bonds, and building long-term wealth.
17,689 articles
Target Struggles as Competition Cripples Growth Prospects
Target is reeling from included margin pressure and a scale battle with bigger retailers, pushing investors to rethin...
Adobe Price Prediction: AI Revenue Growth Sparks Upside
Adobe's AI push lifts revenue and unlocks upside for investors as shares hover near $253. This adobe price prediction...
NVIDIA Could Significantly Boost Sales, Bottleneck Emerges
NVIDIA posted a strong quarterly topline as AI-driven demand pushes data-center sales higher, but a single supply con...
MGK Concentration Drives Most Gains From Five Mega-Cap Stocks
MGK's gains have been propelled by a tight core of five megacaps, a dynamic that boosts returns but also raises risk ...
Where Will Home Depot’s Stock Stand in 2027? Market Outlook
Home Depot posted solid Q1 2026 results, but the path to 2027 hinges on housing demand, consumer sentiment, and strat...
Donald Trump Nancy Pelosi Bet on a Hidden AI Stock
Two of Washington’s most watched political figures disclosed stakes in Vistra, a mid-size energy player poised as AI ...
Micron Technologies Could Reach a $1 Trillion Valuation
Micron reports robust Q3 guidance and signs a five-year strategic deal, fueling optimism that the AI memory cycle cou...
Credo Stock Opens Door for Bulls as Dip Attracts Buyers
Credo Technology posted a strong Q3 with revenue growth and new TAM expansions, even as margins face near-term pressu...
Tech Stocks Plunge. Meanwhile, Costco Climbs to Records
Tech stocks plunge. meanwhile, Costco climbs to fresh all-time highs as investors rotate from high-growth tech to def...
Will ASML, Lilly, or TransDigm Be the Next Big Stock Split?
As Wall Street eyes the next stock split, ASML, Lilly, and TransDigm sit near the top of the list. Analysts say the o...
Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...